Plant sterols and stanols in the treatment of dyslipidemia: New insights intotargets and mechanisms related to cardiovascular risk

Current Pharmaceutical Design

Volumn 17, Issue 9, 2011, Pages 922-932

  Baumgartner, Sabine ^a   Mensink, Ronald P ^a   Plat, Jogchum ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cardiovascular disease; Cholesterol me tabolism; Low density cholesterol; Oxyphytosterols; Plant stanols; Plant sterols; Triacylglycerol

Indexed keywords

CAMPESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; SITOSTEROL; STANOL ESTER; TRIACYLGLYCEROL;

ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HUMAN; INTESTINE ABSORPTION; LIPID METABOLISM; LIPID OXIDATION; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL;

ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DYSLIPIDEMIAS; HUMANS; MOLECULAR TARGETED THERAPY; PHYTOSTEROLS; RISK FACTORS;

EID: 79958219975     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211795428795     Document Type: Article

References (83)

1. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308: 367-72.
2. Cohen JC, Boerwinkle E, Mosley TH, Jr., Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006; 354: 1264-72.
3. Duff CJ, Hooper NM. PCSK9: an emerging target for treatment ofhypercholesterolemia. Expert Opin Ther Targets 2011; 15: 157-68.
4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
5. Ostlund RE, Jr. Phytosterols in human nutrition. Annu Rev Nutr 2002; 22: 533-49.
6. Law M. Plant sterol and stanol margarines and health. BMJ 2000; 320: 861-4.
7. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R.Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003; 78: 965-78.
8. Sudhop T, Sahin Y, Lindenthal B, et al. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinals terol absorption also regulate biliary secretion. Gut 2002; 51: 860-3.
9. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols andcholesterol precursors reflect cholesterol absorption and synthesisin volunteers of a randomly selected male population. Am J Epidemiol 1990; 131: 20-31.
10. Chan YM, Varady KA, Lin Y, et al. Plasma concentrations of plant sterols: physiology and relationship with coronary heart disease. Nutr Rev 2006; 64: 385-402.
11. Gylling H, Miettinen TA. The effects of plant stanol ester in differ-entsubject groups. European Cardiology 2010; 6: 18-21.
12. Abumweis SS, Barake R, Jones PJ. Plant sterols/stanols ascholesterol lowering agents: A meta-analysis of randomizedcontrolled trials. Food Nutr Res 2008; 52.
13. Demonty I, Ras RT, van der Knaap HC, et al. Continuous doseresponserelationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr 2009; 139: 271-84.
14. Brull F, Mensink RP, van den Hurk K, Duijvestijn A, Plat J. TLR2 activation is essential to induce a Th1 shift in human peripheral blood mononuclear cells by plant stanols and plant sterols. J BiolChem 2010; 285: 2951-8.
15. Brull FM, RP. Plat, J. Plant sterols: functional lipids in immune function and inflammation? Clin Lipidol 2009; 4: 355-65.
16. Theuwissen E, Plat J, van der Kallen CJ, van Greevenbroek MM,Mensink RP. Plant stanol supplementation decreases serum triacylglycerols in subjects with overt hypertriglyceridemia. Lipids 2009; 44: 1131-40.
17. Jones PJ, AbuMweis SS. Phytosterols as functional food ingredients: linkages to cardiovascular disease and cancer. Curr Opin Clin Nutr Metab Care 2009; 12: 147-51.
18. Mensink RP, de Jong A, Lutjohann D, Haenen GR, Plat J. Plantstanols dose-dependently decrease LDL-cholesterol concentrations,but not cholesterol-standardized fat-soluble antioxidant concentrations, at intakes up to 9 g/d. Am J Clin Nutr 2010; 92: 24-33.
19. Gylling H, Hallikainen M, Nissinen MJ, Simonen P, Miettinen TA.Very high plant stanol intake and serum plant stanols and non-cholesterolsterols. Eur J Nutr 2009; 49: 111-7.
20. Ayesh R, Weststrate JA, Drewitt PN, Hepburn PA. Safetyevaluation of phytosterol esters. Part 5. Faecal short-chain fattyacid and microflora content, faecal bacterial enzyme activity andserum female sex hormones in healthy normolipidaemic volunteersconsuming a controlled diet either with or without a phytosterolester-enriched margarine. Food Chem Toxicol 1999; 37: 1127-38.
21. Clifton PM, Noakes M, Ross D, Fassoulakis A, Cehun M, Nestel P.High dietary intake of phytosterol esters decreases carotenoids andincreases plasma plant sterol levels with no additional cholesterollowering. J Lipid Res 2004; 45: 1493-9.
22. Davidson MH, Maki KC, Umporowicz DM, et al. Safety andtolerability of esterified phytosterols administered in reduced-fatspread and salad dressing to healthy adult men and women. J AmColl Nutr 2001; 20: 307-19.
23. Gylling H, Puska P, Vartiainen E, Miettinen TA. Retinol, vitaminD, carotenes and alpha-tocopherol in serum of a moderately hypercholesterolemicpopulation consuming sitostanol ester margarine. Atherosclerosis 1999; 145: 279-85.
24. Plat J, Mensink RP. Plant stanol and sterol esters in the control ofblood cholesterol levels: mechanism and safety aspects. Am J Cardiol 2005; 96: 15D-22D.
25. Plat J, van Onselen EN, van Heugten MM, Mensink RP. Effects onserum lipids, lipoproteins and fat soluble antioxidant concentrationsof consumption frequency of margarines and shortenings enrichedwith plant stanol esters. Eur J Clin Nutr 2000; 54: 671-7.
26. Abumweis SS, Vanstone CA, Ebine N, Kassis A, Ausman LM, Jones PJ, Lichtenstein AH. Intake of a single morning dose ofstandard and novel plant sterol preparations for 4 weeks does notdramatically affect plasma lipid concentrations in humans. J Nutr 2006; 136: 1012-6.
27. Derdemezis CS, Filippatos TD, Mikhailidis DP, Elisaf MS. Reviewarticle: effects of plant sterols and stanols beyond low-densitylipoprotein cholesterol lowering. J Cardiovasc Pharmacol Ther 2010; 15: 120-34.
28. Naumann E, Plat J, Kester AD, Mensink RP. The baseline serumlipoprotein profile is related to plant stanol induced changes inserum lipoprotein cholesterol and triacylglycerol concentrations. JAm Coll Nutr 2008; 27: 117-26.
29. Plat J, Brufau G, Dallinga-Thie GM, Dasselaar M, Mensink RP. Aplant stanol yogurt drink alone or combined with a low-dose statinlowers serum triacylglycerol and non-HDL cholesterol in metabolicsyndrome patients. J Nutr 2009; 139: 1143-9.
30. Plana N, Nicolle C, Ferre R, et al. Plant sterol-enriched fermentedmilk enhances the attainment of LDL-cholesterol goal inhypercholesterolemic subjects. Eur J Nutr 2008; 47: 32-9.
31. Judd JT, Baer DJ, Chen SC, et al. Plant sterol esters lower plasmalipids and most carotenoids in mildly hypercholesterolemic adults. Lipids 2002; 37: 33-42.
32. Child P, Kuksis A. Investigation of the role of micellarphospholipid in the preferential uptake of cholesterol over sitosterolby dispersed rat jejunal villus cells. Biochem Cell Biol 1986; 64:847-53.
33. Plat J, Mensink RP. Increased intestinal ABCA1 expressioncontributes to the decrease in cholesterol absorption after plantstanol consumption. FASEB J 2002; 16: 1248-53.
34. Plat J, Mensink RP. Plant stanol esters lower serum triacylglycerolconcentrations via a reduced hepatic VLDL-1 production. Lipids 2009; 44: 1149-53.
35. Tremblay AJ, Lamarche B, Hogue JC, Couture P. Effects ofezetimibe and simvastatin on apolipoprotein B metabolism in maleswith mixed hyperlipidemia. J Lipid Res 2009; 50: 1463-71.
36. Chan DC, Watts GF. Dyslipidaemia in the metabolic syndrome andtype 2 diabetes: pathogenesis, priorities, pharmacotherapies. ExpertOpin Pharmacother 2011; 12: 13-30.
37. Chan DC, Watts GF, Gan SK, Ooi EM, Barrett PH. Effect ofezetimibe on hepatic fat, inflammatory markers, and apolipoproteinB-100 kinetics in insulin-resistant obese subjects on a weight lossdiet. Diabetes Care 2010; 33: 1134-9.
38. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers ofcardiovascular disease risk: a systematic review. Atherosclerosis 2006; 189: 19-30.
39. Skulas-Ray AC, Kris-Etherton PM, Harris WS, Vanden Heuvel JP, Wagner PR, West SG. Dose-response effects of omega-3 fattyacids on triglycerides, inflammation, and endothelial function inhealthy persons with moderate hypertriglyceridemia. Am J ClinNutr 2011; 93: 243-52.
40. Demonty I, Chan YM, Pelled D, Jones PJ. Fish-oils esters of plantsterols improve the lipid profile of dyslipidemic subjects more thando fish-oils or sunflower oil esters of plant sterols. Am J Clin Nutr 2006; 84: 1534-42.
41. Thompson GR. Additive effects of plant sterol and stanol esters tostatin therapy. Am J Cardiol 2005; 96: 37D-9D.
42. Blair SN, Capuzzi DM, Gottlieb SO, Nguyen T, Morgan JM, Cater NB. Incremental reduction of serum total cholesterol and lowdensitylipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol 2000; 86: 46-52.
43. Jakulj L, Trip MD, Sudhop T, von Bergmann K, Kastelein JJ, Vissers MN. Inhibition of cholesterol absorption by the combinationof dietary plant sterols and ezetimibe: effects on plasma lipidlevels. J Lipid Res 2005; 46: 2692-8.
44. Naumann E, Plat J, Mensink RP. Changes in serum concentrationsof noncholesterol sterols and lipoproteins in healthy subjects do notdepend on the ratio of plant sterols to stanols in the diet. J Nutr 2003; 133: 2741-7.
45. Sudhop T, von Bergmann K. Sitosterolemia--a rare disease. Areelevated plant sterols an additional risk factor? Z Kardiol 2004; 93:921-8.
46. Salen G, Horak I, Rothkopf M, et al. Lethal atherosclerosisassociated with abnormal plasma and tissue sterol composition insitosterolemia with xanthomatosis. J Lipid Res 1985; 26: 1126-33.
47. Berge KE, Tian H, Graf GA, et al. Accumulation of dietarycholesterol in sitosterolemia caused by mutations in adjacent ABCtransporters. Science 2000; 290: 1771-5.
48. Assmann G, Cullen P, Erbey J, Ramey DR, Kannenberg F, Schulte H. Plasma sitosterol elevations are associated with an increasedincidence of coronary events in men: results of a nested casecontrolanalysis of the Prospective Cardiovascular Munster(PROCAM) study. Nutr Metab Cardiovasc Dis 2006; 16: 13-21.
49. Matthan NR, Pencina M, LaRocque JM, et al. Alterations incholesterol absorption/synthesis markers characterize Framinghamoffspring study participants with CHD. J Lipid Res 2009; 50: 1927-35.
50. Sudhop T, Gottwald BM, von Bergmann K. Serum plant sterols asa potential risk factor for coronary heart disease. Metabolism 2002;51: 1519-21.
51. Glueck CJ, Speirs J, Tracy T, Streicher P, Illig E, Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterolin 595 hypercholesterolemic subjects, and familial aggregation ofphytosterols, cholesterol, and premature coronary heart disease inhyperphytosterolemic probands and their first-degree relatives. Metabolism 1991; 40: 842-8.
52. Silbernagel G, Fauler G, Hoffmann MM, et al. The associations ofcholesterol metabolism and plasma plant sterols with all-cause andcardiovascular mortality. J Lipid Res 2010; 51: 2384-93.
53. Teupser D, Baber R, Ceglarek U, et al. Genetic regulation of serumphytosterol levels and risk of coronary artery disease. CircCardiovasc Genet 2010; 3: 331-9.
54. Wilund KR, Yu L, Xu F, et al. No association between plasmalevels of plant sterols and atherosclerosis in mice and men. Arterioscler Thromb Vasc Biol 2004; 24: 2326-32.
55. Pinedo S, Vissers MN, von Bergmann K, et al. Plasma levels ofplant sterols and the risk of coronary artery disease: the prospectiveEPIC-Norfolk Population Study. J Lipid Res 2007; 48: 139-44.
56. Fassbender K, Lutjohann D, Dik MG, et al. Moderately elevatedplant sterol levels are associated with reduced cardiovascular risk--the LASA study. Atherosclerosis 2008; 196: 283-8.
57. Strandberg TE, Gylling H, Tilvis RS, Miettinen TA. Serum plantand other noncholesterol sterols, cholesterol metabolism and 22-year mortality among middle-aged men. Atherosclerosis; 210: 282-7.
58. Hovenkamp E, Demonty I, Plat J, Lutjohann D, Mensink RP, Trautwein EA. Biological effects of oxidized phytosterols: a reviewof the current knowledge. Prog Lipid Res 2008; 47: 37-49.
59. Lutjohann D. Sterol autoxidation: from phytosterols tooxyphytosterols. Br J Nutr 2004; 91: 3-4.
60. Bjorkhem I, Meaney S, Diczfalusy U. Oxysterols in humancirculation: which role do they have? Curr Opin Lipidol 2002; 13:247-53.
61. Plat J, Brzezinka H, Lutjohann D, Mensink RP, von Bergmann K. Oxidized plant sterols in human serum and lipid infusions asmeasured by combined gas-liquid chromatography-massspectrometry. J Lipid Res 2001; 42: 2030-8.
62. Grandgirard A, Martine L, Demaison L, et al. Oxyphytosterols arepresent in plasma of healthy human subjects. Br J Nutr 2004; 91:101-6.
63. Silbernagel G, Fauler G, Renner W, et al. The relationships ofcholesterol metabolism and plasma plant sterols with the severityof coronary artery disease. J Lipid Res 2009; 50: 334-41.
64. Weingartner O, Weingartner N, Scheller B, et al. Alterations incholesterol homeostasis are associated with coronary heart diseasein patients with aortic stenosis. Coron Artery Dis 2009; 20: 376-82.
65. Weingartner O, Lutjohann D, Ji S, et al. Vascular effects of dietsupplementation with plant sterols. J Am Coll Cardiol 2008; 51:1553-61.
66. Weingartner O, Pinsdorf T, Rogacev KS, et al. The relationships ofmarkers of cholesterol homeostasis with carotid intima-mediathickness. PLoS One 2010; 5: e13467.
67. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al. Risk factorparadox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007; 10: 433-42.
68. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for theultrasound assessment of endothelial-dependent flow-mediatedvasodilation of the brachial artery: a report of the InternationalBrachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-65.
69. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004; 109: III39-43.
70. Masumoto A, Hirooka Y, Hironaga K, et al. Effect of pravastatinon endothelial function in patients with coronary artery disease(cholesterol-independent effect of pravastatin). Am J Cardiol 2001; 88: 1291-4.
71. de Jongh S, Vissers MN, Rol P, Bakker HD, Kastelein JJ, StroesES. Plant sterols lower LDL cholesterol without improvingendothelial function in prepubertal children with familialhypercholesterolaemia. J Inherit Metab Dis 2003; 26: 343-51.
72. Jakulj L, Vissers MN, Rodenburg J, Wiegman A, Trip MD, Kastelein JJ. Plant stanols do not restore endothelial function inpre-pubertal children with familial hypercholesterolemia despitereduction of low-density lipoprotein cholesterol levels. J Pediatr 2006; 148: 495-500.
73. Hallikainen M, Lyyra-Laitinen T, Laitinen T, et al. Endothelialfunction in hypercholesterolemic subjects: Effects of plant stanoland sterol esters. Atherosclerosis 2006; 188: 425-32.
74. Raitakari OT, Salo P, Gylling H, Miettinen TA. Plant stanol esterconsumption and arterial elasticity and endothelial function. Br J Nutr 2008; 100: 603-8.
75. De Jong A, Plat J, Bast A, Godschalk RW, Basu S, Mensink RP. Effects of plant sterol and stanol ester consumption on lipidmetabolism, antioxidant status and markers of oxidative stress,endothelial function and low-grade inflammation in patients oncurrent statin treatment. Eur J Clin Nutr 2008; 62: 263-73.
76. Landmesser U, Bahlmann F, Mueller M, et al. Simvastatin versusezetimibe: pleiotropic and lipid-lowering effects on endothelialfunction in humans. Circulation 2005; 111: 2356-63.
77. Wong TY, Klein R, Nieto FJ, et al. Retinal microvascularabnormalities and 10-year cardiovascular mortality: a populationbasedcase-control study. Ophthalmology 2003; 110: 933-40.
78. Ikram MK, de Jong FJ, Vingerling JR, et al. Are retinal arteriolaror venular diameters associated with markers for cardiovasculardisorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 2004; 45: 2129-34.
79. Kelly ER, Plat J, Mensink RP, Berendschot TT. Effects of longterm plant sterol and -stanol consumption on the retinalvasculature: A randomized controlled trial in statin users. Atherosclerosis 2010 [Epub ahead of print]
80. Kawasaki R, Tielsch JM, Wang JJ, et al. The metabolic syndromeand retinal microvascular signs in a Japanese population: theFunagata study. Br J Ophthalmol 2008; 92: 161-6.
81. Rajaratnam RA, Gylling H, Miettinen TA. Independent associationof serum squalene and noncholesterol sterols with coronary arterydisease in postmenopausal women. J Am Coll Cardiol 2000; 35:1185-91.
82. Sutherland WHF, Williams MJA, Nye ER, Resticaux NJ, de Jong SA, Walker HL. Associations of plasma noncholesterol sterollevels with severity of coronary artery disease. Nutr MetabCardiovasc Dis 1998; 8: 386-91.
83. Windler A, Zyriax B-C, Kuipers F, Linseisen J, Boeing H. Association of plasma phytosterol concentrations with incidentcoronary heart disease: Data from the CORA study, a case-controlstudy of coronary artery disease in women. Atherosclerosis 2009;203: 284-90.